DDPG in the news
In response to the recent Pfizer takeover bid for Astrazeneca the DDPG released a
letter that highlighted the changing drug discovery landscape in the UK and the effects on the science community. This led to considerable media interaction.
Representatives of the DDPG published
a letter in the Financial Times highlighting the decline of the pharmaceutical industry in the UK. The Association of the British Pharmaceutical Industry (ABPI) published a response to this letter.
Research Fortnight article written by David Phillips: Big pharma is broken, how can we fix it?
Research Fortnight article written by David Fox from the RSC: Keep making the tablets.
Research Fortnight article written by Mark Downs, chief executive of the Royal Society of Biology, Drug discoverers must adapt to a more complex world.
RSC News article,
Removing boundaries: Enabling the movement of researchers across disciplines and the industry-academia interface.
Comments from Mark Downs, chief executive of the Royal Society of Biology, recently featured in the Nature article
AstraZeneca juggernaut heads for Cambridge (£ - pay to view).